1492 Capital Management LLC Editas Medicine, Inc. Transaction History

1492 Capital Management LLC

  • $163 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$14.08 - $27.63 $635,233 - $1.25 Million
-45,116 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $1.2 Million - $1.83 Million
45,116 New
45,116 $1.2 Million
Q1 2021

May 12, 2021
SELL
$39.71 - $90.58 $116,469 - $265,671
-2,933 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$27.07 - $84.35 $79,396 - $247,398
2,933 New
2,933 $206,000

Others Institutions Holding EDIT

# of Institutions
243
Shares Held
69.3M
Call Options Held
564K
Put Options Held
428K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $320M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email